{"id":7538,"date":"2025-02-03T15:52:53","date_gmt":"2025-02-03T14:52:53","guid":{"rendered":"https:\/\/www.isrec.ch\/?post_type=recherche&#038;p=7538"},"modified":"2025-02-03T15:51:18","modified_gmt":"2025-02-03T14:51:18","slug":"the-isrec-foundation-in-15-key-dates","status":"publish","type":"recherche","link":"https:\/\/www.isrec.ch\/en\/research\/the-isrec-foundation-in-15-key-dates\/","title":{"rendered":"The ISREC Foundation in 15 key dates"},"content":{"rendered":"\n<p><strong>1924<\/strong>&nbsp;\u2013 Establishment of the \u201cCentre Anticanc\u00e9reux Romand (CACR)\u201d in Lausanne. The center, co-founded by Profs. Alfred Rosselet et Alfred de Coulon, was involved both in research and in treatment.<\/p>\n\n\n\n<p><strong>1957<\/strong>&nbsp;\u2013 The CACR dedicates itself exclusively to scientific research. Other closely associated aspects such as medical-social work or prevention are outsourced to the cantonal organizations.<\/p>\n\n\n\n<p><strong>June 18, 1964<\/strong>&nbsp;\u2013 Thanks to the efforts of Mr. Rodolphe Stadler (Chairman since 1951) and the remarkable solidarity of the German Swiss with their French Swiss compatriots, ISREC is officially established as a Swiss foundation in the \u201cRue du Bugnon\u201d building.<\/p>\n\n\n\n<p><strong>1964<\/strong>&nbsp;\u2013 The institute has 48 employees. Its director and co-founder is Prof. Henri Isliker.<\/p>\n\n\n\n<p><strong>1972<\/strong>&nbsp;\u2013 The National Councilor Jean-Jacques Cevey is elected Chairman of the Foundation and works to consolidate the financial basis of the Institute and, with the help of the Confederation, the state of Vaud, the Swiss Cancer League and the \u201cRomande\u201d Lottery, to acquire a research building in Epalinges which meets the needs of the institute.<\/p>\n\n\n\n<p><strong>1973<\/strong>&nbsp;\u2013 Thanks to collaborations between the ISREC and the Institute of Biochemistry, the WHO and the Ludwig Cancer Research Institute, a critical mass of more than 150 scientists is reached. The space available in the laboratory building at the \u201cRue du Bugnon\u201d rapidly becomes totally insufficient.<\/p>\n\n\n\n<p><strong>1976<\/strong>&nbsp;\u2013 Inauguration of the new building in the presence of the Federal Councilor H. H\u00fcrlimann.<\/p>\n\n\n\n<p><strong>1978<\/strong>&nbsp;\u2013 After 18 years devoted first to CACR and then to ISREC, the founding director of ISREC, Prof. Henri Isliker, resigns. The torch is taken up by Prof. Bernhard Hirt, who also directs the ISREC during 18 years.<\/p>\n\n\n\n<p><strong>1994<\/strong>&nbsp;\u2013 Professor Georges Muller is elected president.<\/p>\n\n\n\n<p><strong>1996<\/strong>&nbsp;\u2013 Prof. Michel Aguet is the new director. In addition to basic research, his policy is to promote collaborations with clinical and applied research groups.<\/p>\n\n\n\n<p><strong>2001<\/strong>&nbsp;\u2013 The ISREC is appointed \u201cleading house\u201d of the National Center of Competence in Research (NCCR) in the field of molecular oncology. This project also supports its partner institutions, the Ludwig Institute and the Institute of Biochemistry, and creates an opportunity to bridge the existing gap between fundamental and clinical research.<\/p>\n\n\n\n<p><strong>2005<\/strong>&nbsp;\u2013 Mr. Yves J. Paternot is elected president.&nbsp;<\/p>\n\n\n\n<p><strong>2008<\/strong>&nbsp;\u2013 Integration of the ISREC research groups into the EPFL \u2013 School of Life Sciences.<\/p>\n\n\n\n<p><strong>2018<\/strong>&nbsp;\u2013 Inauguration of the AGORA \u2013 P\u00f4le de recherche sur le cancer. Initiated in 2013 by the ISREC Foundation, this center is the result of a partnership between the CHUV, the UNIL, the EPFL, the LICR, the HUG and the UNIGE. Under one roof, physicians, biologists, geneticists, immunologists, bioinformaticians and bioengineers join forces to address the numerous challenges posed by this disease, so as to develop and implement novel therapeutic approaches for patients.<\/p>\n\n\n\n<p><strong>Today<\/strong>&nbsp;\u2013 The ISREC Foundation is committed on a daily basis to supporting projects with a broad diagnostic and therapeutic potential for innovations in cancer research.<\/p>\n","protected":false},"featured_media":0,"template":"","cat-recherche":[105],"class_list":["post-7538","recherche","type-recherche","status-publish","hentry","cat-recherche-60-history-page"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/recherche\/7538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/recherche"}],"about":[{"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/types\/recherche"}],"wp:attachment":[{"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/media?parent=7538"}],"wp:term":[{"taxonomy":"cat-recherche","embeddable":true,"href":"https:\/\/www.isrec.ch\/en\/wp-json\/wp\/v2\/cat-recherche?post=7538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}